Market Overview

UPDATE: Piper Jaffray Downgrades Allscripts Healthcare Solutions to Underweight on Weak Results

Share:
Related MDRX
Benzinga's Option Alert Recap From May 19
Benzinga's Top Upgrades, Downgrades For May 15, 2017

Piper Jaffray reduced its rating on Allscripts Healthcare Solutions (NASDAQ: MDRX) from Neutral to Underweight and lowered its price target from $12 to $7.

Piper Jaffray commented, "We are downgrading to UW given bookings are accelerating downward, margins are going nowhere, and the Company attempts to integrate a portfolio of outdated products while embarking on an ambitious release cycle of new products. About the best one can hope for from here is a takeout, which we still don't think is enough of a reason to support owning the shares. We estimate $15 is the best-case scenario on a takeout (2x EV/Rev). We think the risk/reward supports an Underweight rating and $7 target."

Allscripts Healthcare Solutions closed at $12.26 on Thursday.

Latest Ratings for MDRX

DateFirmActionFromTo
May 2017Bank of AmericaInitiates Coverage OnNeutral
Mar 2017Wells FargoUpgradesMarket PerformOutperform
Feb 2017DoughertyUpgradesNeutralBuy

View More Analyst Ratings for MDRX
View the Latest Analyst Ratings

Posted-In: Piper JaffrayAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (MDRX)

View Comments and Join the Discussion!